(CC) Chemours - Ratings and Ratios
Refrigerants,Titanium Dioxide,Fluoropolymer Additives,Performance Chemical
CC EPS (Earnings per Share)
CC Revenue
Description: CC Chemours
Chemours Co, listed on the NYSE under the ticker symbol CC, is a US-based company operating in the Diversified Chemicals sub-industry. The companys financials indicate significant challenges, including a negative Return on Equity (RoE) of -80.89%, suggesting substantial losses relative to shareholder equity.
The stocks valuation metrics show a Forward Price-to-Earnings (P/E) ratio of 7.86, which, while low, must be considered in the context of the companys current financial performance and industry conditions. The Market Capitalization stands at approximately $1.824 billion, indicating a mid-cap status.
Key economic drivers for Chemours Co include demand trends in the chemicals industry, particularly in segments related to its product portfolio, such as refrigerants, advanced materials, and industrial chemicals. The companys performance is also influenced by factors like raw material costs, regulatory changes (e.g., environmental and safety regulations), and global economic conditions affecting industrial production and consumption.
To evaluate the stocks potential, critical KPIs to monitor include revenue growth, gross margin trends, operating cash flow generation, and debt-to-equity ratio. These metrics will provide insights into the companys ability to recover from current challenges and achieve long-term sustainability. Additionally, tracking industry-specific indicators, such as production volumes and pricing trends for key products, can offer valuable context for assessing Chemours competitive position and financial prospects.
From a trading perspective, the stocks high Beta of 1.590 indicates that its price movements are more volatile than the broader market, suggesting a higher risk profile. This characteristic, combined with the current price being significantly below its 52-week high and SMA200, may indicate potential for recovery or contrarian investment opportunities, contingent upon a thorough analysis of the companys fundamentals and market conditions.
CC Stock Overview
| Market Cap in USD | 2,557m |
| Sub-Industry | Diversified Chemicals |
| IPO / Inception | 2015-07-01 |
CC Stock Ratings
| Growth Rating | -49.8% |
| Fundamental | 19.8% |
| Dividend Rating | 33.2% |
| Return 12m vs S&P 500 | -18.1% |
| Analyst Rating | 3.80 of 5 |
CC Dividends
| Dividend Yield 12m | 4.18% |
| Yield on Cost 5y | 3.94% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 80.9% |
| Payout Ratio | 55.4% |
CC Growth Ratios
| Growth Correlation 3m | 83.2% |
| Growth Correlation 12m | -70.1% |
| Growth Correlation 5y | -44.6% |
| CAGR 5y | -11.95% |
| CAGR/Max DD 3y | -0.16 |
| CAGR/Mean DD 3y | -0.39 |
| Sharpe Ratio 12m | -0.54 |
| Alpha | 0.03 |
| Beta | 0.538 |
| Volatility | 44.83% |
| Current Volume | 3514.7k |
| Average Volume 20d | 2922k |
| Stop Loss | 16.3 (-5.1%) |
| Signal | -0.27 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-420.0m TTM) > 0 and > 6% of Revenue (6% = 352.7m TTM) |
| FCFTA -0.13 (>2.0%) and ΔFCFTA -15.83pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.27% (prev 24.06%; Δ -2.79pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 258.0m > Net Income -420.0m (YES >=105%, WARN >=100%) |
| Net Debt (-258.0m) to EBITDA (237.0m) ratio: -1.09 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (150.2m) change vs 12m ago 0.08% (target <= -2.0% for YES) |
| Gross Margin 18.25% (prev 19.49%; Δ -1.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 79.77% (prev 79.13%; Δ 0.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.37 (EBITDA TTM 237.0m / Interest Expense TTM 268.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.70
| (A) 0.17 = (Total Current Assets 3.10b - Total Current Liabilities 1.85b) / Total Assets 7.49b |
| (B) 0.17 = Retained Earnings (Balance) 1.26b / Total Assets 7.49b |
| (C) -0.01 = EBIT TTM -98.0m / Avg Total Assets 7.37b |
| (D) 0.13 = Book Value of Equity 974.0m / Total Liabilities 7.25b |
| Total Rating: 1.70 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 19.82
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield -16.03% = -5.0 |
| 3. FCF Margin -16.89% = -6.34 |
| 4. Debt/Equity 17.47 = -2.50 |
| 5. Debt/Ebitda 17.47 = -2.50 |
| 6. ROIC - WACC (= -5.84)% = -7.30 |
| 7. RoE -80.89% = -2.50 |
| 8. Rev. Trend -26.30% = -1.97 |
| 9. EPS Trend -21.26% = -1.06 |
What is the price of CC shares?
Over the past week, the price has changed by +5.47%, over one month by +14.85%, over three months by +60.80% and over the past year by -2.97%.
Is Chemours a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CC is around 17.91 USD . This means that CC is currently overvalued and has a potential downside of 4.31%.
Is CC a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.4 | -10.1% |
| Analysts Target Price | 15.4 | -10.1% |
| ValueRay Target Price | 19.1 | 11.1% |
Last update: 2025-09-18 04:32
CC Fundamental Data Overview
CCE Cash And Equivalents = 502.0m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 7.5245
P/S = 0.4371
P/B = 10.7884
P/EG = 1.6685
Beta = 1.598
Revenue TTM = 5.88b USD
EBIT TTM = -98.0m USD
EBITDA TTM = 237.0m USD
Long Term Debt = 4.10b USD (from longTermDebt, last quarter)
Short Term Debt = 38.0m USD (from shortTermDebt, last quarter)
Debt = 4.14b USD (Calculated: Short Term 38.0m + Long Term 4.10b)
Net Debt = -258.0m USD (from netDebt column, last quarter)
Enterprise Value = 6.19b USD (2.56b + Debt 4.14b - CCE 502.0m)
Interest Coverage Ratio = -0.37 (Ebit TTM -98.0m / Interest Expense TTM 268.0m)
FCF Yield = -16.03% (FCF TTM -993.0m / Enterprise Value 6.19b)
FCF Margin = -16.89% (FCF TTM -993.0m / Revenue TTM 5.88b)
Net Margin = -7.15% (Net Income TTM -420.0m / Revenue TTM 5.88b)
Gross Margin = 18.25% ((Revenue TTM 5.88b - Cost of Revenue TTM 4.80b) / Revenue TTM)
Tobins Q-Ratio = 6.36 (Enterprise Value 6.19b / Book Value Of Equity 974.0m)
Interest Expense / Debt = 1.59% (Interest Expense 66.0m / Debt 4.14b)
Taxrate = 32.28% (41.0m / 127.0m)
NOPAT = -98.0m (EBIT -98.0m, no tax applied on loss)
Current Ratio = 1.68 (Total Current Assets 3.10b / Total Current Liabilities 1.85b)
Debt / Equity = 17.47 (Debt 4.14b / last Quarter total Stockholder Equity 237.0m)
Debt / EBITDA = 17.47 (Net Debt -258.0m / EBITDA 237.0m)
Debt / FCF = -4.17 (Debt 4.14b / FCF TTM -993.0m)
Total Stockholder Equity = 519.2m (last 4 quarters mean)
RoA = -5.61% (Net Income -420.0m, Total Assets 7.49b )
RoE = -80.89% (Net Income TTM -420.0m / Total Stockholder Equity 519.2m)
RoCE = -2.12% (Ebit -98.0m / (Equity 519.2m + L.T.Debt 4.10b))
RoIC = -2.12% (NOPAT -98.0m / Invested Capital 4.62b)
WACC = 3.72% (E(2.56b)/V(6.70b) * Re(8.0%)) + (D(4.14b)/V(6.70b) * Rd(1.59%) * (1-Tc(0.32)))
Shares Correlation 3-Years: -6.06 | Cagr: -0.45%
Discount Rate = 8.0% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -993.0m)
EPS Correlation: -21.26 | EPS CAGR: -24.14% | SUE: 1.09 | # QB: 1
Revenue Correlation: -26.30 | Revenue CAGR: -3.42% | SUE: N/A | # QB: None
Additional Sources for CC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle